Cargando…
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes
AIMS/HYPOTHESIS: Antibodies specific to oxidative post-translational modifications (oxPTM) of insulin (oxPTM-INS) are present in most individuals with type 1 diabetes, even before the clinical onset. However, the antigenic determinants of such response are still unknown. In this study, we investigat...
Autores principales: | Strollo, Rocky, Vinci, Chiara, Man, Y. K. Stella, Bruzzaniti, Sara, Piemonte, Erica, Alhamar, Ghadeer, Briganti, Silvia Irina, Malandrucco, Ilaria, Tramontana, Flavia, Fanali, Chiara, Garnett, James, Buccafusca, Roberto, Guyer, Perrin, Mamula, Mark, James, Eddie A., Pozzilli, Paolo, Ludvigsson, Johnny, Winyard, Paul G., Galgani, Mario, Nissim, Ahuva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729141/ https://www.ncbi.nlm.nih.gov/pubmed/36207582 http://dx.doi.org/10.1007/s00125-022-05812-4 |
Ejemplares similares
-
Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children
por: Strollo, Rocky, et al.
Publicado: (2017) -
Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014) -
Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases
por: Ryan, Brent J., et al.
Publicado: (2014) -
The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
por: Napoli, Nicola, et al.
Publicado: (2014) -
Corrigendum to “The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes”
por: Napoli, Nicola, et al.
Publicado: (2017)